206 related articles for article (PubMed ID: 16781483)
1. The diagnosis of polycythemia vera: new tests and old dictums.
Tefferi A
Best Pract Res Clin Haematol; 2006; 19(3):455-69. PubMed ID: 16781483
[TBL] [Abstract][Full Text] [Related]
2. The rise and fall of red cell mass measurement in polycythemia vera.
Tefferi A
Curr Hematol Rep; 2005 May; 4(3):213-7. PubMed ID: 15865874
[TBL] [Abstract][Full Text] [Related]
3. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
4. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
[TBL] [Abstract][Full Text] [Related]
5. Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility.
Sirhan S; Fairbanks VF; Tefferi A
Cancer; 2005 Jul; 104(1):213-5. PubMed ID: 15889449
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Thurmes PJ; Steensma DP
Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
[TBL] [Abstract][Full Text] [Related]
8. A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).
Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):81-6. PubMed ID: 20425336
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and therapy of polycythemia vera.
Lengfelder E; Merx K; Hehlmann R
Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
[TBL] [Abstract][Full Text] [Related]
10. Influence of the assays of endogenous colony formation and serum erythropoietin on the diagnosis of polycythemia vera and essential thrombocythemia.
Mossuz P;
Semin Thromb Hemost; 2006 Apr; 32(3):246-50. PubMed ID: 16673278
[TBL] [Abstract][Full Text] [Related]
11. [A 53-year-old man with headache and concentration difficulties].
Vik A; Berntsen R; Isaksen V; Haug E; Hansen JB
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2647-9. PubMed ID: 16231451
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of Janus kinase 2 prevents polycythemia in mice.
Mathur A; Mo JR; Kraus M; O'Hare E; Sinclair P; Young J; Zhao S; Wang Y; Kopinja J; Qu X; Reilly J; Walker D; Xu L; Aleksandrowicz D; Marshall G; Scott ML; Kohl NE; Bachman E
Biochem Pharmacol; 2009 Aug; 78(4):382-9. PubMed ID: 19413997
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of polycythemia vera based on bone marrow pathology.
Thiele JM; Kvasnicka HM
Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.
Silver RT; Chow W; Orazi A; Arles SP; Goldsmith SJ
Blood; 2013 Sep; 122(11):1881-6. PubMed ID: 23900239
[TBL] [Abstract][Full Text] [Related]
15. The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.
Jakovic L; Gotic M; Gisslinger H; Soldatovic I; Sefer D; Tirnanic M; Lekovic D; Jovanovic MP; Schalling M; Gisslinger B; Beham-Schmid C; Simonitsch-Klupp I; Thiele J
Ann Hematol; 2018 Sep; 97(9):1581-1590. PubMed ID: 29717365
[TBL] [Abstract][Full Text] [Related]
16. [Polycythemia vera].
Rain JD
Rev Prat; 2005 Oct; 55(15):1659-68. PubMed ID: 16334202
[TBL] [Abstract][Full Text] [Related]
17. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
Johansson P; Safai-Kutti S; Lindstedt G; Suurküla M; Kutti J
Acta Haematol; 2002; 108(1):1-7. PubMed ID: 12145459
[TBL] [Abstract][Full Text] [Related]
18. Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
Maslah N; Ravdan O; Drevon L; Verger E; Belkhodja C; Chomienne C; Cassinat B; Kiladjian JJ; Giraudier S; Schlageter MH
Br J Haematol; 2022 Feb; 196(3):676-680. PubMed ID: 34562020
[TBL] [Abstract][Full Text] [Related]
19. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
20. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study.
Remacha AF; Montserrat I; Santamaria A; Oliver A; Barceló MJ; Parellada M
Haematologica; 1997; 82(4):406-10. PubMed ID: 9299851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
